Macular edema after siponimod treatment for multiple sclerosis: a case report and literature review
Abstract Background As a modulator of the sphingosine 1-phosphate receptor, siponimod is administered as a therapeutic intervention for multiple sclerosis. A previous phase 3 study first reported siponimod-associated macular edema. Since that report, there were only few relevant reports in clinical...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2023-07-01
|
| Colecção: | BMC Neurology |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s12883-023-03333-0 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|